Try for Free
Sign In
Accelerator

The Forge

Open
Norway
English
was 23:59 on 28 February 2025. upcoming : late 2025

Test your idea and explore market interest.

Norway’s biotech accelerator transforming ideas to companies

What is it for:-

Support biotech solution development

What can the funding be used for?

Biotech/health solution developmentLaboratory validationRegulatory preparationBusiness modelingNetwork and partnership activities

What is the goal :

Create strong biotech companies

Funding scope

Non-financial (expertise/networks)

Final report includes:

Non-confidential pitch deck
The Forge
https://www.digitallifenorway.org/competence-areas/innovation/news/the-forge-biotechnology-ac.html
Generate Now
Close
en_USEN
en_USEN nb_NONB

Grant Application

The Forge

Open
Norway
English
was 23:59 on 28 February 2025. upcoming : late 2025

Test your idea and explore market interest.


Oppstart 1 supports early-stage startups that want to validate whether there’s a paying market for their innovative solution. This grant helps you gain key market insights and early feedback from customers, partners, or investors — before you invest heavily in development.

What is it for:-

  • Startups that:
  • Are under 3 years old (in some cases up to 5) and not majority-owned by established companies
  • Have an innovative solution that is clearly new to the market
  • Have conducted some initial market analysis
  • Can describe their competitive advantage and customer focus
  • Are ready to test assumptions with real users through a minimum viable solution

What can the funding be used for?

  • Market research and customer interviews
  • MVP development (lean, resource-light)
  • Early testing and validation with potential users
  • Activities that build network and relevant competence
  • Costs that help you avoid building something based on untested assumptions

What is the goal :

To achieve “market acceptance” — meaning someone external is willing to take a risk alongside you. This could be through pilot agreements, capital from partners, or interest from early customers or investors.

Funding scope

  • Up to NOK 100,000 (100%) for companies without employees
  • Up to NOK 200,000 (75%) for companies with employees (includes internal time + external costs)

Final report includes:

Results from activities, key learnings, next steps, SWOT analysis, expected capital needs, and plans for future development and commercialization.

The Forge
https://www.digitallifenorway.org/competence-areas/innovation/news/the-forge-biotechnology-ac.html